HAYLEY SCHANK: Open Payments
NPI 1295517399 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $236 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $42 |
| ABBVIE INC. | 2 | $30 |
| Amgen Inc. | 1 | $29 |
| KYOWA KIRIN, INC. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: QULIPTA, CRYSVITA, PREVNAR 20, TRUMENBA, GARDASIL 9, SHINGRIX, Ozempic, Jornay PM.
Industry payments across ID — which companies pay providers there.
